Project Grant K01HL181683
Award Date 9/15/25
Completion Date 6/30/30
Dollars Obligated $167K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Temple University aims to investigate the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among students at highest risk for food insecurity and obesity. The project seeks to build on the principal investigator's existing K01 award, utilizing a multi-method approach to determine if the equity-focused...
- This $100,998 project grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to The Regents of the University of California, San Francisco (UCSF) aims to evaluate the effects of universal pre-kindergarten (pre-K) access policies on the cardiovascular health of approximately 28 million parents of young children in the United States. The study will leverage the National Health Interview Survey to examine how parenthood, universal pre-K, and...
- This $674,300 Project Grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) examines implementation of policy changes to the National School Lunch and Breakfast Programs (NSLP/SBP). The goal is to describe the impact of NSLP/SBP policy changes, such as new flexibilities for school nutrition standards, and identify ways to improve effectiveness and equity of program implementation. The project involves a three-phase study. Phase 1 will...
- This Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) provides $394,417 to The Leland Stanford Junior University to conduct a social media counter-marketing campaign to improve diet quality among young adults (ages 18-29). The key objectives of the project are to: 1) Optimize a counter-marketing campaign that leverages young adults' values and attitudes to encourage healthier food choices, 2) Test whether the counter-marketing...
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA Program 93.837 Cardiovascular Diseases Research) aims to determine if cancer directly promotes cardiovascular disease and explore potential therapies. The $1,102,957 award to The Leland Stanford Junior University, commencing on April 15, 2025 and scheduled for completion on January 31, 2032, will fund a multidisciplinary research program across population genetics, cardio-oncology, and translational medicine. The...
- The National Heart, Lung, and Blood Institute awarded a $719,140 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to New York University to conduct the "OPT-FRESH: Optimizing Online Purchasing of Fruits, Vegetables, and Legumes for Low-Income Families" project. The project aims to test a multi-component intervention to address barriers to online healthy food selection among low-income families in New York City, with a focus on increasing the purchase of...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $107,834 project grant to The Leland Stanford Junior University. The grant, which runs from January 21, 2025 to January 2, 2026, aims to investigate the cardiovascular impact of novel gut-hormone agonists, including semaglutide (GLP-1R), tirzepatide (GLP-1R/GIPR), and retatrutide (GLP-1R/GIPR/GCGR). The research will involve comprehensive profiling of...
- This Project Grant award of $609,850 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a longitudinal study to examine food insecurity as a social determinant of cardiovascular health in a marginalized immigrant Latino population. The study will collect mixed-methods data from 450 Latino immigrants to characterize patterns of food insecurity over time and how it, along with trauma, impacts cardiovascular disease risk and psychological...
- This $131,085 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a 5-year research project led by Dr. Arianne Caudal at The Leland Stanford Junior University to elucidate the cardiac-protective mechanisms of SGLT2 inhibitors. The project aims to leverage human induced pluripotent stem cell-derived cardiovascular cells, single-cell RNA sequencing, metabolomics, and large-scale drug-protein interaction determination to...